Edwards Lifesciences - Multiplikator Forward P/S EW
Edwards Lifesciences' leadership in the development of cardiac systems and its robust R&D drive the price action. On the GURU.Markets platform, the company's expected P/S illustrates market expectations, where the value 4.50 describes the current level. Simultaneously, the business is implementing strict raw material certification to reduce toxic emissions and is transitioning to eco-packaging using renewable energy at its plants.
Edwards Lifesciences Inc. (EW) - rincian metrik lan laporan keuangan
- rega saiki lan proyeksi nilai saham:
- rincian nilai pasar emiten:
- statistik nilai buku emiten:
- data liabilitas lan likuiditas perusahaan:
Utang marang Ekuitas Edwards Lifesciences|EW - Utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang ekuitas Edwards Lifesciences|EW - Kewajiban utang agregat|Utang-utang marang kapitalisasi buku Edwards Lifesciences Inc.|EW - Utang jangka dawa|Utang jangka cendhak perusahaan Edwards Lifesciences|Indikator likuiditas cepet edwards.com
- rincian asil keuangan lan kelipatan valuasi:
EW - Bathi resik|Proyeksi bathi mangsa ngarep Edwards Lifesciences|EW - Periode bali modal bisnis|Rega marang bathi mangsa ngarep Edwards Lifesciences Corp|EW - Rasio kapitalisasi marang bathi lan wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Edwards Lifesciences Inc.|EW - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben saham (EPS TTM) Edwards Lifesciences|EW - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan edwards.com|EW - Wutah bathi saben saham ing taun iki|Prakiraan wutah bathi saben saham kanggo taun ngarep Edwards Lifesciences
- data dodolan lan asil:
Ringkesan analisis perusahaan:Edwards Lifesciences Corporation EW
The market values Edwards Lifesciences (EW) as a high-tech leader with premium growth potential. The company's expected P/S ratio compares current market capitalization with projected revenue, determining the fair value of future sales flows. This chart confirms the valuation's resilience, as inelastic demand for unique TAVR systems allows the business to maintain high pricing power, transforming the asset into a defensive tool with a high-quality fundamental profile.
Analisis pesaing
Multiplikator Forward P/S BSX (Boston Scientific Corporation)|RMD: Kapitalisasi marang prakiraan pendapatan|OmniPod - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake Zimmer Biomet Holdings ZBH|COO: Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan aligntech.com|GMED (Globus Medical) - Multiplikator Forward P/S|Multiplikator Forward P/S TransMedics Group Inc|Rasio rega marang prakiraan pendapatan ATEC Spine (ATEC)|Rasio rega marang prakiraan pendapatan AORT (Artivion Corp)|Enovis Corporation - Multiplikator forward rega marang pendapatan|Rega forward marang dodolan IART|Establishment Labs Holdings Inc. - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Beta Bionics, Inc.|Iradimed (IRMD) - Rasio rega marang prakiraan pendapatan|Prakiraan rega marang pendapatan Embecta Health EMBC|Multiplikator forward rega marang pendapatan TNDM|Multiplikator Forward P/S axogeninc.com|Multiplikator Forward P/S SIBN|Rasio kapitalisasi marang dodolan sing dikarepake Orthofix Medical|Rasio rega marang prakiraan pendapatan Bioventus Corp BVS|KIDS (OrthoPediatrics Corp) - Rega mangsa ngarep marang pendapatan|TMCI - Rasio rega marang prakiraan pendapatan|blade.com (SRTA) - Multiplikator forward rega marang pendapatan|CARL: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep RxSight Inc (RXST)|Rasio rega marang prakiraan pendapatan ClearPoint Neuro Inc.|Kapitalisasi marang prakiraan pendapatan STXS (Stereotaxis Corporation)|Multiplikator forward rega marang pendapatan STIM (Neuronetics, Inc.)|Rasio rega marang pendapatan sing dikarepake SGHT|Multiplikator Forward P/S OBIO (Orchestra BioMed, Inc.)|Anika Therapeutics Inc. (ANIK) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|InspireMD Corp - Multiplikator Forward P/S|ZJYL (Jin Medical International) - Kapitalisasi marang prakiraan pendapatan|VANI (vivani.com) - Multiplikator forward rega marang pendapatan|Multiplikator forward rega marang pendapatan Xtant Medical|NMTC (NeuroOne Medical Technologies Corporation) - Multiplikator Forward P/S|Multiplikator Forward P/S Modular Med|Rasio rega marang prakiraan pendapatan Myomo, Inc (MYO)|COCH (Envoy Medical Inc) - Rega forward marang dodolan|Multiplikator Forward P/S VVOS (Vivos Therapeutics)|NVNO: Kapitalisasi marang prakiraan pendapatan|SINT - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake Tenon Medical Inc. TNON|LFWD (ReWalk Robotics Ltd) - Multiplikator forward rega marang pendapatan|Autonomix Medical - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan INVO Fertility Inc|Rasio rega marang prakiraan pendapatan BBLG|Multiplikator Forward P/S AXNX|Rasio kapitalisasi marang dodolan sing dikarepake BIOLASE Inc.|Multiplikator Forward P/S DYNT (Dynatronics)|FNA (Paragon 28 Inc.) - Rega mangsa ngarep marang pendapatan|INVO Bio - Multiplikator Forward P/S
